Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19724037 [patent_doc_number] => 20250026788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-23 [patent_title] => PEPTIDES FOR THE TREATMENT OF CHRONICALLY ACTIVE AUTOIMMUNE INFLAMMATION [patent_app_type] => utility [patent_app_number] => 18/572259 [patent_app_country] => US [patent_app_date] => 2022-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9597 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18572259 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/572259
PEPTIDES FOR THE TREATMENT OF CHRONICALLY ACTIVE AUTOIMMUNE INFLAMMATION Jun 22, 2022 Pending
Array ( [id] => 18337989 [patent_doc_number] => 20230129938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => METHODS OF TREATING NEUROLOGICAL DISEASES [patent_app_type] => utility [patent_app_number] => 17/844647 [patent_app_country] => US [patent_app_date] => 2022-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21470 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844647 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/844647
METHODS OF TREATING NEUROLOGICAL DISEASES Jun 19, 2022 Pending
Array ( [id] => 19473875 [patent_doc_number] => 12103951 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-01 [patent_title] => Use of CGRP receptor antagonists in neuroprotection and neurological disorders [patent_app_type] => utility [patent_app_number] => 17/806834 [patent_app_country] => US [patent_app_date] => 2022-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 29671 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17806834 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/806834
Use of CGRP receptor antagonists in neuroprotection and neurological disorders Jun 13, 2022 Issued
Array ( [id] => 18364673 [patent_doc_number] => 20230146264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => Treatment of Ascites [patent_app_type] => utility [patent_app_number] => 17/831556 [patent_app_country] => US [patent_app_date] => 2022-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3085 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831556 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/831556
Treatment of Ascites Jun 2, 2022 Abandoned
Array ( [id] => 19497643 [patent_doc_number] => 20240336661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => PEPTIDES DERIVED FROM RUMINOCOCCUS TORQUES [patent_app_type] => utility [patent_app_number] => 18/564398 [patent_app_country] => US [patent_app_date] => 2022-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34611 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564398 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/564398
PEPTIDES DERIVED FROM RUMINOCOCCUS TORQUES Jun 1, 2022 Pending
Array ( [id] => 19923022 [patent_doc_number] => 12297293 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-13 [patent_title] => Peptide compounds targeting PD-1 receptor as well as preparation and applications thereof [patent_app_type] => utility [patent_app_number] => 18/568525 [patent_app_country] => US [patent_app_date] => 2022-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 0 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18568525 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/568525
Peptide compounds targeting PD-1 receptor as well as preparation and applications thereof May 31, 2022 Issued
Array ( [id] => 19380940 [patent_doc_number] => 20240270810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => PREPARATION AND APPLICATION OF POLYPEPTIDE [patent_app_type] => utility [patent_app_number] => 18/288796 [patent_app_country] => US [patent_app_date] => 2022-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288796 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/288796
PREPARATION AND APPLICATION OF POLYPEPTIDE May 29, 2022 Pending
Array ( [id] => 20192272 [patent_doc_number] => 20250268982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES [patent_app_type] => utility [patent_app_number] => 18/563420 [patent_app_country] => US [patent_app_date] => 2022-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10426 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563420 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/563420
COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES May 25, 2022 Pending
Array ( [id] => 17852197 [patent_doc_number] => 20220282239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY [patent_app_type] => utility [patent_app_number] => 17/749004 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5844 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17749004 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/749004
MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY May 18, 2022 Abandoned
Array ( [id] => 19316833 [patent_doc_number] => 20240238373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => Use of Erythropoietin (EPO) or Erythropoiesis-Stimulating Agent (ESA) to Treat Osteomyelitis, Bone Infection, and Bone Inflammation [patent_app_type] => utility [patent_app_number] => 18/290297 [patent_app_country] => US [patent_app_date] => 2022-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8409 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18290297 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/290297
Use of Erythropoietin (EPO) or Erythropoiesis-Stimulating Agent (ESA) to Treat Osteomyelitis, Bone Infection, and Bone Inflammation May 15, 2022 Pending
Array ( [id] => 17895440 [patent_doc_number] => 20220305102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => TREATMENT OF HAEMATOLOGICAL MALIGNANCIES [patent_app_type] => utility [patent_app_number] => 17/744568 [patent_app_country] => US [patent_app_date] => 2022-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47677 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744568 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/744568
TREATMENT OF HAEMATOLOGICAL MALIGNANCIES May 12, 2022 Pending
Array ( [id] => 19464140 [patent_doc_number] => 20240317809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => Engineered Antimicrobial Peptides and Usage Thereof [patent_app_type] => utility [patent_app_number] => 18/290214 [patent_app_country] => US [patent_app_date] => 2022-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37773 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -65 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18290214 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/290214
Engineered Antimicrobial Peptides and Usage Thereof May 11, 2022 Pending
Array ( [id] => 17837721 [patent_doc_number] => 20220275026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => IL-2RBETA BINDING COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/741020 [patent_app_country] => US [patent_app_date] => 2022-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 111515 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 310 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17741020 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/741020
IL-2RBETA BINDING COMPOUNDS May 9, 2022 Abandoned
Array ( [id] => 18250565 [patent_doc_number] => 20230077604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => ANTIMICROBIAL PEPTIDES AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 17/738572 [patent_app_country] => US [patent_app_date] => 2022-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7598 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 226 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738572 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/738572
Antimicrobial peptides and methods of using same May 5, 2022 Issued
Array ( [id] => 20163888 [patent_doc_number] => 20250255934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-14 [patent_title] => COMPOSITIONS FOR TREATING INFLAMMATORY AIRWAY DISEASE AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/559118 [patent_app_country] => US [patent_app_date] => 2022-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17682 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559118 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/559118
COMPOSITIONS FOR TREATING INFLAMMATORY AIRWAY DISEASE AND USES THEREOF May 5, 2022 Pending
Array ( [id] => 19297740 [patent_doc_number] => 20240226306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => TREM-2/DAP-12 INHIBITORS FOR TREATING LUNG DISEASE AND INJURY AND COMBINATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 18/560300 [patent_app_country] => US [patent_app_date] => 2022-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38513 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18560300 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/560300
TREM-2/DAP-12 INHIBITORS FOR TREATING LUNG DISEASE AND INJURY AND COMBINATIONS THEREOF May 4, 2022 Pending
Array ( [id] => 18034487 [patent_doc_number] => 20220378702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => PEPTIDE-LIPID CONJUGATES [patent_app_type] => utility [patent_app_number] => 17/737862 [patent_app_country] => US [patent_app_date] => 2022-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34984 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737862 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/737862
PEPTIDE-LIPID CONJUGATES May 4, 2022 Pending
Array ( [id] => 18198175 [patent_doc_number] => 20230051694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => POLYPEPTIDE FRAGMENT B (MP-B) AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/737058 [patent_app_country] => US [patent_app_date] => 2022-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2845 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737058 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/737058
POLYPEPTIDE FRAGMENT B (MP-B) AND USE THEREOF May 4, 2022 Abandoned
Array ( [id] => 18124145 [patent_doc_number] => 20230009757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-12 [patent_title] => COMBINATION THERAPY FOR C3 INHIBITION [patent_app_type] => utility [patent_app_number] => 17/719074 [patent_app_country] => US [patent_app_date] => 2022-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 105502 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719074 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/719074
COMBINATION THERAPY FOR C3 INHIBITION Apr 11, 2022 Pending
Array ( [id] => 20744032 [patent_doc_number] => 12643923 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-06-02 [patent_title] => Method of clarifying a crude protein solution [patent_app_type] => utility [patent_app_number] => 18/549552 [patent_app_country] => US [patent_app_date] => 2022-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 0 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549552 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/549552
Method of clarifying a crude protein solution Apr 10, 2022 Issued
Menu